Doctor profile · Federal record
Dr. ZUHAL ARZOMAND, M.D.
Rheumatology Physician (CMS: RHEUMATOLOGY) · Internal Medicine Physician · ALEXANDRIA, VA
- NPI 1992187272
- Accepts Medicare
- MIPS 60.0 / 100 · 2023
- 11 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
101 S WHITING ST STE 105
ALEXANDRIA, VA 223043416
(703) 751-8804
Credentials & registration
- NPI registered
- June 2015 — 11 yrs on file
- Profile last updated
- June 12, 2020
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- Virginia #0101269426 · Rhode Island #LP03540
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1992187272. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
413
Distinct HCPCS
4
Medicare allowed
$49,434
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 265 | 98 | $143 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 76 | 13 | $1 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 55 | 55 | $184 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 17 | 11 | $87 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 535. This provider delivers 0.8× the peer median.Open Payments
Industry payments received
All-time total
$1,499
Transactions
52
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 9 | $270.03 | |
| Mallinckrodt Hospital Products Inc. | 5 | $210.58 | |
| ABBVIE INC. | 8 | $159.92 | |
| UCB, Inc. | 8 | $155.18 | |
| Amgen Inc. | 6 | $148.23 | |
| Lilly USA, LLC | 3 | $129.21 | |
| AstraZeneca Pharmaceuticals LP | 1 | $125.80 | |
| Novartis Pharmaceuticals Corporation | 4 | $115.62 | |
| GlaxoSmithKline, LLC. | 4 | $88.70 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $28.67 | |
| PFIZER INC. | 1 | $26.65 | |
| Aurinia Pharma U.S., Inc. | 1 | $22.20 | |
| Kiniksa Pharmaceuticals International, plc | 1 | $18.30 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
325
Patients
124
Total drug cost
$224,211
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 83 | 34 | $778 |
| Hydroxychloroquine Sulfate | Generic | 52 | 23 | $5,681 |
| Methotrexate (Methotrexate Sodium) | Brand | 44 | 16 | $1,867 |
| Diclofenac Sodium | Generic | 39 | 20 | $801 |
| Duloxetine Hcl | Generic | 30 | 18 | $758 |
| Meloxicam | Generic | 20 | 13 | $103 |
| Pregabalin | Generic | 17 | 0 | $596 |
| Rinvoq (Upadacitinib) | Brand | 16 | 0 | $102,604 |
| Allopurinol | Generic | 12 | 0 | $260 |
| Xeljanz Xr (Tofacitinib Citrate) | Brand | 12 | 0 | $110,764 |